Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase
about
Guidelines for the use and interpretation of assays for monitoring autophagyGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotesThe orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPKCholine supplementation promotes hepatic insulin resistance in phosphatidylethanolamine N-methyltransferase-deficient mice via increased glucagon actionBerberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesisModeling integrated cellular machinery using hybrid Petri-Boolean networksInhibition of mammalian translation initiation by volatile anestheticsThe glucagon receptor is required for the adaptive metabolic response to fastingCB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptorsApelin is necessary for the maintenance of insulin sensitivity.O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteinsExendin-4 improves blood glucose control in both young and aging normal non-diabetic mice, possible contribution of beta cell independent effects.Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function.Mechanisms involved in the coordinate regulation of mTORC1 by insulin and amino acids.C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest.ERK and Akt signaling pathways function through parallel mechanisms to promote mTORC1 signalingGlucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism.Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes.RETRACTED: Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver.Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides.The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis.AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues.Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between substrates for interaction with raptor.Role of AMP-activated protein kinase in healthy and diseased hearts.AMP-activated protein kinase and its downstream transcriptional pathwaysPreserved protein synthesis in the heart in response to acute fasting and chronic food restriction despite reductions in liver and skeletal muscle.Visualization of Compartmentalized Kinase Activity Dynamics Using Adaptable BimKARs.The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding.Glucagon acts in a dominant manner to repress insulin-induced mammalian target of rapamycin complex 1 signaling in perfused rat liverLKB1 and AMP-activated protein kinase control of mTOR signalling and growth.AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.Physiologic action of glucagon on liver glucose metabolismThe metabolic actions of glucagon revisitedMetabolic impact of glucagon deficiency.
P2860
Q21996341-CC34AF82-F9BE-4D5A-91B9-6B2CCBADA9E1Q22676705-168DF742-5603-4FBD-A95C-A040B953332BQ23757358-A55BCF7E-F46F-40B9-ACEA-5475C9F5FD50Q27682265-7DFA1161-D087-44D7-93A9-CD648030E3EFQ28279881-16412094-81D2-4545-B1BF-ADF87535BF4BQ28477076-36CD9BD4-3B48-4B11-B92B-02312CFE493CQ28534912-B9937D5B-DA16-4A88-ABF0-3EAB1EF71BC0Q28573022-08C5B752-2A06-4EFB-BF41-168D941EDB2AQ28594780-F3B07107-9690-4563-AEA0-24C63F34F02DQ28610813-ED519F03-7E34-4135-AC9B-E80B51AF72EAQ33589049-48D3035F-697B-4FFB-80FD-C0993A6DC065Q33907013-04439DAA-DAFF-4140-A58D-651859877AE3Q33927198-B094F4C7-50BC-4BFD-9626-31CC991D7D13Q34085728-F3C7E8A6-33C5-4A23-83CC-FCA86E9903C0Q34215218-CD546238-6087-4289-B47F-E8561ED31DBAQ34358845-C493D10E-7302-4C1E-8555-AB87C2A74311Q34624351-17B2525F-B2CD-4433-82C4-A74747A6C6E4Q34852643-75672E52-FD65-44D3-BD13-5481D5193BB1Q34979291-A938BE9C-6F3A-490F-B539-7EDA89E50F29Q35147964-3197246D-6FF4-4812-9D6A-7E56E470E2ADQ35310496-B28E687F-AF97-4E82-BABC-FBE6EDFC46AAQ35405051-4E32471F-FBF8-471C-8AA2-9D05B06A8A53Q35612382-90BC9AE1-1B84-4A7B-984B-15E8DEA4EEFDQ35688212-BCA65653-EB67-4E02-993D-371C64DE88AEQ36078757-A1A94385-957C-4878-B93A-6F546B2C570EQ36466762-B5E585A7-1EB6-4695-9F6E-2D82FEE10D0CQ36482341-A0EB507A-5F9C-431E-BF3E-A54C4D8DDEE8Q36508534-26059777-BC3F-4B3F-9865-701A30011F06Q36537821-18B69C33-0C67-49D3-8B56-E5525C07A360Q36756228-79BC3557-595D-46E5-A4E8-8258202C7747Q36805463-082F75F0-F7B3-41B8-9925-D7D467327065Q36909070-C23FD2A1-FE9A-4D1E-86B2-C7C929622303Q36922115-22A44277-3092-41BB-81E4-00309F6D61FFQ37298067-AF8E9FC3-0150-4478-B888-47DBE9947007Q37383513-624FE2B9-6D66-4286-9FDB-7D1DB572B3B8Q37401935-41BC5C39-75A5-43E5-BF93-1C461F8A310EQ37608516-DF2E4B98-76A1-49B9-826C-31B1B0186B0DQ37726825-6F266988-7E46-4683-95BF-A15F6E47DEEFQ37801277-8C0B19B5-A71E-4402-A39B-D0B9AC1A175AQ37913526-8B31E210-A000-44E6-AF72-9E06032E17BE
P2860
Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase
description
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2004
@ast
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/12/24)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/12/24)
@nl
наукова стаття, опублікована в грудні 2004
@uk
name
Glucagon represses signaling t ...... g AMP-activated protein kinase
@ast
Glucagon represses signaling t ...... g AMP-activated protein kinase
@en
Glucagon represses signaling t ...... g AMP-activated protein kinase
@nl
type
label
Glucagon represses signaling t ...... g AMP-activated protein kinase
@ast
Glucagon represses signaling t ...... g AMP-activated protein kinase
@en
Glucagon represses signaling t ...... g AMP-activated protein kinase
@nl
prefLabel
Glucagon represses signaling t ...... g AMP-activated protein kinase
@ast
Glucagon represses signaling t ...... g AMP-activated protein kinase
@en
Glucagon represses signaling t ...... g AMP-activated protein kinase
@nl
P2093
P356
P1476
Glucagon represses signaling t ...... g AMP-activated protein kinase
@en
P2093
Brett A. Siegfried
Leonard S. Jefferson
Scot R. Kimball
P304
54103–54109
P356
10.1074/JBC.M410755200
P407
P577
2004-12-24T00:00:00Z